DUBLIN , Feb. 12, 2024 /PRNewswire/ -- The "Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, With Executive Guides and Customization 2023 to 2027" report has been added to
ResearchAndMarkets.com's offering.
Diagnostics are leading the charge in reducing the threat posed by antimicrobial resistance. Will these technologies solve the problem before new antibiotics come along? New diagnostic technologies, beyond gene sequencing, are under development to capture this growing market.
The publisher has looked at the technology picture, giving you a plain language understanding of the different ways pathogens, and infections can be diagnosed. The report has identified the 6 Key Large Pathogen Opportunities in this space and developed market forecasts. The report profiles over 30 companies, large and small, working in this area. Antibiotic Resistance Diagnostics Recent Developments
FDA Clears New bioMerieux Diagnostic System and Panel
Selux Diagnostics Phenotyping System Gets FDA Approval
New diagnostics to tackle drug resistant infections Three companies join forces to tackle antimicrobial resistance (AMR)
T2 Biosystems Exercises BARDA Option
OpGen to Ramp up Use of Acuitas AMR Gene Panel BD Partners With Pfizer, Wellcome to Study AMR Dx OpGen Receives FDA Clearance for AMR Panel MicroGenDx, OrthoKey Clinic and OrthoKey Surgery
BioMerieux Receives CE Mark for Vitek Clinical Microbiology System Hologic to Acquire Mobidiag
Campylobacter strains exchange genes
Disinfection spreads antimicrobial resistance
Rapid diagnostics linked to optimal antibiotics
DNAe Technology SARS-CoV-2 Sequences
Infections with foodborne bacteria becoming harder to treat Dust is sharing antibiotic resistance genes
1.1 Antimicrobial Resistance - Strategic Situation Analysis
1.2 Guide for Executives and Business Development Staff
1.3 Guide for Management Consultants and Investment Advisors
2 Introduction and Market Definition
2.1 The Threat and Opportunity of Antimicrobial Resistance
2.2 Defining the Opportunity
2.4 Perspective: Healthcare and the IVD Industry
2.5 Spending on Diagnostics
3 Overview of a Dynamic Market
3.1 Players in a Dynamic Market
3.1.1 Diagnostic Test Developer
3.1.2 Instrumentation Supplier
3.1.3 Chemical/Reagent Supplier
3.1.5 Independent Clinical Laboratory
3.1.6 Public National/regional Laboratory
3.1.7 Hospital Laboratory
3.1.8 Physicians Office Lab (POLS)
3.1.10 Certification Body
3.2 Understanding Antimicrobial Resistance
3.3 The Changing Road to New Antibiotics & Technologies
3.4 The Key Role of Diagnostics in AMR
4 The Market Opportunity of AMR
4.1 The Key Large Market Opportunities in AMR
4.1.1 Streptococcus Pneumoniae (DRSP)
4.1.2 Campylobacter (DRC)
4.1.4 Staphylococcus aureus (MRSA)
4.1.5 Neisseria gonorrhoeae (DRNG)
4.2 Diagnostic Technology Development Opportunities
4.2.1 What's Wrong with Microbiology
4.2.3 Multiplex vs. POC/Rapid
4.2.4 The Miracle of Genetics
4.2.5 From Multiple Pathogens to All Pathogens - The Next Next Generation
4.2.6 Gene Sequence Diagnostics WITHOUT the Sequencing.
4.2.7 Markers of Resistance.
4.2.8 What Happens to the Microbiology Lab?
5 Antibiotic Resistance Diagnostics Recent Developments
7 The Global Market for Antimicrobial Resistance Diagnostics
7.1 Global Market Overview by Country.
7.2 Global Market by Technology
8 Global Antibiotic Resistance Diagnostic Markets - By Pathogen
8.1 Drug Resistant Streptococcus Pneumoniae - DRSP
8.2 Drug Resistant Campylobacter - DRC
8.4 Methicillin Resistant Staphylococcus Aureus - MRSA
8.5 Drug Resistant Neisseria Gonorrhoeae - DRNG
8.6 Drug Resistant Salmonella - DRNTS
9 Global Antibiotic Resistance Diagnostic Markets - by Technology
9.5 Mass Spectrometry - MS
9.6 Rapid and Point of Care - Rapid/POC
For more information about this report visit https://www.researchandmarkets.com/r/f7gwgt
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets